An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques

Signal Transduct Target Ther. 2023 Apr 29;8(1):173. doi: 10.1038/s41392-023-01425-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibody Formation
  • COVID-19 Vaccines / therapeutic use
  • COVID-19*
  • Humans
  • Macaca
  • Mice
  • SARS-CoV-2
  • Vaccines, Virus-Like Particle*

Substances

  • COVID-19 Vaccines
  • Vaccines, Virus-Like Particle